News
Researchers at Johns Hopkins University have developed SRT-H, an AI that autonomously guided a da Vinci robot through complex ...
Study offers an important advancement in understanding symptom dynamics during the menopause transition, particularly by challenging the dominance of menstrual-based staging. Although criteria such as ...
A laundry-stealing cat with expensive taste has puzzled and delighted a neighborhood in Auckland, New Zealand, by committing ...
A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...
We thank Sara Osborne and colleagues for their interest in our trial.1 Ligelizumab phase 3 studies in patients with chronic spontaneous urticaria (CSU)1 were done with a study design and in ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery ...
A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.
This digital health care company seeks to support women through every stage of womanhood, even—and especially—the ...
A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...
A new myTomorrows survey of physicians in the United States highlights the need for smarter, AI-driven tools to overcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results